What Is Humanin? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. Humanin is not FDA-approved for human therapeutic use. Products sold online as Humanin, HN, HNG, S14G-Humanin, mitochondrial peptide, anti-aging peptide, or “research use only” Humanin may carry safety, quality, legal, and regulatory risks.
Quick answer
Humanin is a mitochondrial-derived peptide encoded within the mitochondrial genome. It is one of the first and best-studied mitochondrial-derived peptides, often abbreviated HN. Humanin is studied for cytoprotection, neuroprotection, oxidative-stress defense, mitochondrial function, metabolism, insulin sensitivity, cardiovascular biology, fertility, inflammation, and aging-related disease models. Preclinical evidence is substantial, especially in cell and animal models of neurodegeneration, metabolic dysfunction, cardiovascular stress, and oxidative injury. Human clinical evidence is still limited, and Humanin is not FDA-approved for Alzheimer’s disease, Parkinson’s disease, diabetes, infertility, cardiovascular disease, anti-aging, longevity, fatigue, or general mitochondrial optimization.
Key facts about Humanin
| Question | Answer |
|---|---|
| What is Humanin? | A mitochondrial-derived peptide studied for cytoprotection, neuroprotection, metabolism, and aging biology. |
| Other names | HN, Humanin peptide, mitochondrial-derived peptide Humanin, HNG, S14G-Humanin, HN analogs. |
| Peptide class | Mitochondrial-derived peptide / cytoprotective peptide / mitochondrial signaling peptide. |
| Main mechanism | Proposed cytoprotective effects through mitochondrial signaling, oxidative-stress reduction, anti-apoptotic pathways, GP130/IL6ST receptor-complex signaling, STAT3, AKT, ERK, metabolic regulation, and mitochondrial function. |
| FDA-approved? | No. Humanin is not an FDA-approved drug. |
| Main studied uses | Neuroprotection, Alzheimer’s disease models, Parkinson’s disease models, insulin sensitivity, diabetes models, cardiovascular disease, mitochondrial dysfunction, fertility, inflammation, and aging biology. |
| Human evidence level | Limited. Human biomarker and association studies exist, but strong human clinical outcome evidence is lacking. |
| Animal/lab evidence level | Moderate to strong preclinical evidence for cytoprotective, neuroprotective, metabolic, cardiovascular, and mitochondrial-stress mechanisms. |
| Common online claims | “Anti-aging peptide,” “mitochondrial peptide,” “longevity peptide,” “Alzheimer’s peptide,” “metabolic peptide,” “fertility peptide,” “energy peptide.” |
| Sports status | Not found here as specifically named on the WADA prohibited list; athletes should verify current WADA/Global DRO status before use. |
| Main safety concern | Lack of FDA approval, lack of robust human safety and efficacy data, unknown long-term effects, route-specific uncertainty, and risks from unapproved online products. |
What is Humanin?
Humanin is a small mitochondrial-derived peptide. It is encoded by a short open reading frame within mitochondrial DNA and is considered part of a newer class of signaling peptides called mitochondrial-derived peptides.
Humanin was originally identified in research related to Alzheimer’s disease and cell survival. It later became a major research focus because it appears to protect cells against multiple types of stress in experimental systems.
A PubMed review on Humanin as a regulator of lifespan and healthspan describes Humanin as a mitochondrial-derived peptide encoded by short open reading frames within the mitochondrial genome. A PMC review on the emerging role of Humanin describes Humanin as a mitochondrial-derived peptide with cytoprotective effects in multiple experimental disease models.
The key distinction:
Humanin is a real mitochondrial signaling peptide with serious research behind it, but it is not an FDA-approved anti-aging drug, Alzheimer’s treatment, metabolic therapy, fertility treatment, or mitochondrial supplement.
How does Humanin work?
Humanin’s mechanism is complex and still being studied.
Research discusses Humanin in relation to:
- Mitochondrial stress response
- Cytoprotection
- Anti-apoptotic signaling
- Oxidative-stress reduction
- Mitochondrial function
- GP130/IL6ST receptor-complex signaling
- STAT3 signaling
- AKT signaling
- ERK1/2 signaling
- Insulin sensitivity
- Inflammatory signaling
- Neuroprotection
- Cardiovascular protection
- Cellular survival under metabolic or oxidative stress
A PubMed study reported that Humanin acts through a GP130/IL6ST receptor complex to activate AKT, ERK1/2, and STAT3 signaling pathways. A PMC review on mitochondrially derived peptides discusses Humanin as a mitochondrial-derived peptide that can localize to mitochondria and may affect mitochondrial respiration and membrane potential.
In plain English:
Humanin is studied because it appears to help cells survive stress, especially mitochondrial, oxidative, metabolic, and neurodegenerative stress.
But mechanism is not proof.
A protective effect in cells or animals does not prove that Humanin treats Alzheimer’s disease, reverses aging, improves fertility, lowers diabetes risk, extends lifespan, improves athletic recovery, or safely boosts mitochondrial function in humans.
What is Humanin used for?
Humanin is commonly discussed for neuroprotection, Alzheimer’s disease, Parkinson’s disease, metabolic health, diabetes, cardiovascular disease, fertility, inflammation, mitochondrial dysfunction, anti-aging, and longevity. These uses differ sharply in evidence quality.
| Use | Evidence level | What is known | What is not known | |---|---|---| | Neuroprotection | Strong preclinical evidence | Humanin and Humanin analogs protect cells and animal models from neurotoxic and oxidative stress. | Human clinical benefit in Alzheimer’s, Parkinson’s, or dementia is not established. | | Alzheimer’s disease models | Preclinical / mechanistic | Humanin was originally studied in relation to Alzheimer’s-related toxicity and cell survival. | It is not an FDA-approved Alzheimer’s treatment. | | Parkinson’s disease models | Preclinical | Reviews discuss neuroprotective effects in neurodegeneration models. | Human Parkinson’s treatment benefit is not established. | | Metabolic health | Preclinical plus biomarker research | Humanin is studied in insulin sensitivity, glucose metabolism, and metabolic stress. | Human diabetes-treatment efficacy is not established. | | Cardiovascular disease | Preclinical / biomarker research | Humanin may affect endothelial function, oxidative stress, and cardiovascular stress models. | It is not an approved cardiovascular therapy. | | Fertility / reproduction | Preclinical and association research | Humanin has been studied in reproductive aging and gonadal stress models. | Human fertility-treatment benefit is not established. | | Aging and longevity | Preclinical / biomarker research | Humanin levels and signaling are studied in aging biology and lifespan/healthspan models. | Human anti-aging or longevity benefit is not proven. | | Mitochondrial dysfunction | Mechanistic | Humanin is a mitochondrial-derived peptide with stress-response biology. | It is not a general mitochondrial disease treatment. | | Athletic recovery / performance | Unsupported | Online claims extrapolate from mitochondrial and cytoprotective biology. | No strong human evidence supports performance or recovery use. | | Online research-use Humanin | High uncertainty | Sellers may market Humanin or HNG as research peptides. | Quality, sterility, identity, concentration, absorption, dosing, and legality may be unknown. |
What does the research show?
Human evidence
Human evidence for Humanin is still limited.
Some human studies evaluate Humanin levels as biomarkers in aging, metabolic disease, cardiovascular disease, fertility, or mitochondrial health. For example, a 2025 PMC review on Humanin and MOTS-c biomarker potential discusses Humanin and MOTS-c as mitochondrial-derived peptides with neuroprotective and metabolic functions and reviews their potential biomarker roles.
These studies are useful, but they are not the same as clinical trials proving that Humanin injections, sprays, capsules, or research-use products treat disease.
The practical interpretation:
Humanin has human biology relevance, but strong human therapeutic evidence is lacking.
Neuroprotection evidence
Humanin is most famous for neuroprotection.
A PMC review on Humanin as a harbinger of mitochondrial-derived peptides describes Humanin as the first small peptide of a putative family of mitochondrial-derived peptides and discusses its cytoprotective actions against various disease-related stresses.
A PMC review on neuroprotective action of Humanin and Humanin analogues reviews research supporting Humanin’s neuroprotective activity and the neuroprotective effects of specific Humanin analogs.
The practical interpretation:
Humanin has meaningful preclinical neuroprotection evidence, but preclinical neuroprotection has not translated into an approved Alzheimer’s or Parkinson’s therapy.
Metabolism and insulin-sensitivity evidence
Humanin is also studied in metabolic disease.
A PubMed review describes Humanin as a mitochondrial-derived cytoprotective peptide with protective effects in several cell types and discusses therapeutic potential in metabolic diseases.
A PubMed review on Humanin as a regulator of lifespan and healthspan discusses Humanin’s role in metabolism, aging biology, and disease models.
The practical interpretation:
Humanin is relevant to metabolism and insulin-sensitivity research, but it is not an FDA-approved diabetes, obesity, or metabolic-disease drug.
Cardiovascular evidence
Humanin has been studied in cardiovascular biology.
A PubMed review on Humanin in cardiovascular function discusses Humanin as a possible marker for mitochondrial function in cardiovascular disease and as a potential pharmacological strategy in endothelial dysfunction.
The practical interpretation:
Cardiovascular Humanin research is promising but investigational. It does not establish Humanin as a heart-disease treatment.
Eye and retinal evidence
Humanin has also been studied in retinal and eye-disease models.
A PubMed study reported that the mitochondrial-derived peptide Humanin protected retinal pigment epithelial cells against oxidative stress-induced cell death and restored mitochondrial function in experimental models.
The practical interpretation:
Humanin may be relevant to retinal oxidative-stress biology, but it is not an approved treatment for macular degeneration or retinal disease.
Aging and longevity evidence
Humanin is frequently discussed in aging research.
A PMC review on Humanin and pathophysiological roles in aging describes Humanin as a small mitochondrial-derived peptide under study with potential therapeutic applications for age-related diseases.
This is where online marketing often goes too far.
The practical interpretation:
Humanin is an aging-biology research peptide, not a proven anti-aging or longevity therapy.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “Humanin is a mitochondrial-derived peptide.” | Supported | Humanin is encoded by a short open reading frame within mitochondrial DNA. |
| “Humanin has cytoprotective effects.” | Supported preclinically | Cell and animal studies support cytoprotective effects across stress models. |
| “Humanin is neuroprotective.” | Supported preclinically | Reviews and models support neuroprotective activity. |
| “Humanin treats Alzheimer’s disease.” | Not established | Alzheimer’s-related preclinical data do not prove clinical benefit. |
| “Humanin improves insulin sensitivity.” | Supported preclinically / investigational | Metabolic research is promising, but human treatment efficacy is not established. |
| “Humanin treats diabetes.” | Not established | It is not an FDA-approved diabetes drug. |
| “Humanin improves cardiovascular health.” | Investigational | Cardiovascular models and biomarker research exist, but no approved therapy exists. |
| “Humanin reverses aging.” | Unsupported | Aging biology research does not prove human anti-aging benefit. |
| “Humanin is FDA-approved.” | False | Humanin is not an FDA-approved drug. |
| “Humanin is safe because it is naturally occurring.” | False | Natural mitochondrial origin does not prove safety when administered as a drug. |
| “Research-use Humanin is clinically proven.” | False | Research-use products are not FDA-approved consumer therapeutic products. |
Is Humanin FDA-approved?
No. Humanin is not FDA-approved.
There is no FDA-approved Humanin product for Alzheimer’s disease, dementia, Parkinson’s disease, diabetes, insulin resistance, infertility, cardiovascular disease, macular degeneration, fatigue, anti-aging, longevity, mitochondrial dysfunction, athletic recovery, or any other therapeutic use.
The key distinction:
Humanin is an experimental mitochondrial-derived peptide, not an FDA-approved medication.
Is Humanin legal?
Humanin’s legal status depends on product type, route, jurisdiction, intended use, and how it is sold.
The practical answer is simple:
Humanin is not an FDA-approved drug, and online availability does not mean it is legally marketed for human therapeutic use.
Some sellers market Humanin, HNG, or Humanin analogs as research peptides, mitochondrial peptides, anti-aging peptides, or longevity peptides. That does not make them safe, approved, legal, or appropriate for consumer use.
The blunt version:
Buying “research use only” Humanin online is not the same as receiving an FDA-approved prescription medication from a legitimate pharmacy.
Is Humanin banned in sports?
I did not find Humanin specifically named on the WADA prohibited list in the sources reviewed here.
However, athletes should be careful for several reasons:
- Peptide products can be contaminated or mislabeled.
- Anti-doping status can change.
- Unapproved pharmacologic substances can create risk depending on classification, route, or accompanying ingredients.
- Online peptide products may contain substances other than what is listed on the label.
The WADA Prohibited List and USADA prohibited-list guidance should be checked directly before use.
The practical advice:
Athletes should verify Humanin through Global DRO, WADA, or USADA before using it and should avoid unapproved online peptide products.
Safety and side effects
Humanin should not be treated as risk-free.
Possible or theoretical concerns include:
- Injection-site reactions for injectable products
- Nasal irritation for nasal products
- Gastrointestinal discomfort for oral products
- Immune or allergic reactions
- Unknown long-term safety
- Unknown route-specific safety
- Unknown effects on cancer or proliferative disease biology
- Unknown effects in pregnancy or breastfeeding
- Unknown interaction risk with diabetes drugs, cardiovascular drugs, fertility treatments, neuroactive drugs, or immune-modulating therapies
- Product-quality and sterility risks from online sources
- Mislabeling or incorrect concentration
- Contamination risk
- Unclear absorption depending on formulation
- Overstated anti-aging and disease-treatment claims
The biggest safety issue is uncertainty.
Humanin has substantial preclinical biology, but there is no FDA-approved label, no standard approved dose, no broad human safety database, and no consumer-product quality framework.
A serious evaluation of Humanin should separate endogenous mitochondrial signaling from injecting, spraying, or ingesting synthetic Humanin products bought online.
Humanin vs similar peptides and drugs
| Compound | Category | Main difference | |---|---| | Humanin | Mitochondrial-derived peptide | Studied for cytoprotection, neuroprotection, metabolism, cardiovascular biology, and aging. | | HNG / S14G-Humanin | Humanin analog | Modified Humanin analog often used in research for stronger cytoprotective activity. | | MOTS-c | Mitochondrial-derived peptide | Studied more for metabolic regulation, AMPK-related signaling, insulin sensitivity, and exercise-like effects. | | SHLPs | Small humanin-like peptides | Related mitochondrial-derived peptides with distinct biology. | | Elamipretide / SS-31 | Mitochondrial cardiolipin-binding peptide | FDA-approved as Forzinity for a specific Barth syndrome indication; not the same as Humanin. | | CoQ10 | Mitochondrial cofactor/supplement | Not a mitochondrial-derived peptide. | | Metformin | Metabolic drug | FDA-approved diabetes drug with mitochondrial and AMPK-related effects, not a peptide. | | GLP-1 drugs | Incretin drugs | Approved examples exist for diabetes and obesity, but they are not mitochondrial-derived peptides. |
The key distinction:
Humanin belongs in the mitochondrial-derived peptide category. It is not a GLP-1 drug, growth hormone peptide, repair peptide, cosmetic peptide, or FDA-approved mitochondrial drug.
Why is Humanin sold as “research use only”?
Some online sellers use “research use only” language to sell Humanin or Humanin analogs outside normal drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Endogenous Humanin | Naturally occurring mitochondrial-derived peptide biology. |
| Laboratory Humanin | Research peptide used in controlled experimental settings. |
| Humanin analogs | Modified research peptides such as HNG or S14G-Humanin. |
| FDA-approved Humanin | Does not currently exist. |
| Research-use Humanin | Not an FDA-approved consumer therapeutic product. |
| Online mitochondrial peptide | Higher risk for identity, purity, sterility, concentration, absorption, dosing, and safety problems. |
How to evaluate Humanin claims online
| Claim | What to verify |
|---|---|
| “FDA-approved Humanin” | False. Humanin is not FDA-approved. |
| “Clinically proven anti-aging peptide” | Look for controlled human trials, not only aging-biology reviews. |
| “Treats Alzheimer’s disease” | Not established. Preclinical neuroprotection does not prove human dementia benefit. |
| “Improves insulin sensitivity” | Check whether evidence is human clinical outcome data or animal/metabolic-marker research. |
| “Treats diabetes” | False as an approved claim. Humanin is not an approved diabetes drug. |
| “Protects the heart” | Investigational. Cardiovascular biology does not prove clinical treatment benefit. |
| “Boosts mitochondria” | Too vague. Ask what outcome was measured in humans. |
| “Reverses aging” | Unsupported. |
| “No side effects because it is natural” | False. Natural biological origin does not prove safety when administered as a drug. |
| “Research use only” | This does not mean safe, legal, approved, or appropriate for human use. |
| “Safe for athletes” | Verify through WADA, USADA, or Global DRO before use. |
| “Third-party tested” | Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, endotoxin, microbial, and stability data. |
Bottom line
Humanin is a mitochondrial-derived peptide with important cytoprotective, neuroprotective, metabolic, cardiovascular, and aging-biology research. It is one of the foundational peptides in the mitochondrial-derived peptide category.
The most defensible conclusion is:
Humanin is a promising research peptide, not a proven consumer therapy. It is not FDA-approved, strong human clinical outcome evidence is lacking, and online claims about Alzheimer’s disease, anti-aging, diabetes, fertility, cardiovascular protection, mitochondrial optimization, and longevity often go beyond the current evidence.
FAQ
What is Humanin?
Humanin is a mitochondrial-derived peptide encoded within mitochondrial DNA. It is studied for cytoprotection, neuroprotection, mitochondrial function, metabolism, and aging biology.
What does Humanin do?
Humanin appears to protect cells from oxidative, metabolic, inflammatory, and mitochondrial stress in experimental models. It is also studied for neuroprotection, insulin sensitivity, cardiovascular biology, and aging-related disease models.
Is Humanin FDA-approved?
No. Humanin is not FDA-approved for Alzheimer’s disease, Parkinson’s disease, diabetes, infertility, cardiovascular disease, anti-aging, longevity, mitochondrial dysfunction, or any other therapeutic use.
Is Humanin the same as MOTS-c?
No. Humanin and MOTS-c are both mitochondrial-derived peptides, but they are different peptides with different mechanisms and research focuses.
Is Humanin the same as Elamipretide?
No. Humanin is a mitochondrial-derived peptide encoded by mitochondrial DNA. Elamipretide is a mitochondria-targeted cardiolipin-binding peptide approved as Forzinity for a specific Barth syndrome indication.
Does Humanin help Alzheimer’s disease?
Humanin has preclinical neuroprotective evidence related to Alzheimer’s disease models, but it is not an FDA-approved Alzheimer’s treatment and human clinical benefit is not established.
Does Humanin improve insulin sensitivity?
Preclinical research suggests Humanin may influence insulin sensitivity and metabolic regulation, but it is not an FDA-approved diabetes or insulin-resistance treatment.
Is Humanin an anti-aging peptide?
Humanin is studied in aging biology, but strong human evidence does not establish it as an anti-aging or longevity therapy.
Is Humanin safe?
Humanin does not have enough human safety data to call it safe for consumer use. Online Humanin products also create identity, purity, sterility, concentration, absorption, and contamination risks.
Is Humanin legal?
Humanin is not an FDA-approved drug. Online sales as a research peptide do not mean it is legally marketed for human therapeutic use.
Is Humanin banned in sports?
I did not find Humanin specifically named on the WADA prohibited list in the sources reviewed here. Athletes should verify current status with WADA, USADA, or Global DRO before use.
Why do sellers call Humanin “research use only”?
Sellers often use “research use only” language because Humanin is not FDA-approved for consumer therapeutic use. The phrase does not make the product safe, legal, approved, or clinically proven.
What is the biggest risk with Humanin?
The biggest risks are using an unapproved mitochondrial peptide without adequate human safety data, relying on preclinical evidence instead of clinical outcome trials, and buying online products with uncertain identity, purity, sterility, concentration, and safety.
Sources
- PubMed: The mitochondrial-derived peptide Humanin is a regulator of lifespan and healthspan
- PMC: The emerging role of the mitochondrial-derived peptide Humanin
- PMC: Humanin, a harbinger of mitochondrial-derived peptides?
- PubMed: Humanin, a harbinger of mitochondrial-derived peptides?
- PMC: Neuroprotective Action of Humanin and Humanin Analogues
- PubMed: Mitochondrial-derived peptide Humanin as therapeutic target
- PubMed: Humanin, a mitochondrial-derived peptide in the treatment of metabolic diseases
- PMC: Humanin and Its Pathophysiological Roles in Aging
- PMC: Humanin, a mitochondrial-derived peptide released by astrocytes
- PMC: Mitochondrially derived peptides as novel regulators of metabolism
- PubMed: The mitochondrial-derived peptide Humanin activates the GP130/IL6ST receptor complex
- PubMed: Role of Humanin in cardiovascular function
- PubMed: Humanin protects retinal pigment epithelial cells against oxidative stress
- PMC: The Molecular Structure and Role of Humanin in Neural and Metabolic Disorders
- PMC: Insights into the Biomarker Potential of Humanin and MOTS-c
- WADA: Prohibited List
- USADA: WADA Prohibited List Guidance
Frequently asked questions
What is Humanin?
Humanin is a mitochondrial-derived peptide encoded within mitochondrial DNA. It is studied for cytoprotection, neuroprotection, mitochondrial function, metabolism, and aging biology.
What does Humanin do?
Humanin appears to protect cells from oxidative, metabolic, inflammatory, and mitochondrial stress in experimental models. It is also studied for neuroprotection, insulin sensitivity, cardiovascular biology, and aging-related disease models.
Is Humanin FDA-approved?
No. Humanin is not FDA-approved for Alzheimer's disease, Parkinson's disease, diabetes, infertility, cardiovascular disease, anti-aging, longevity, mitochondrial dysfunction, or any other therapeutic use.
Is Humanin the same as MOTS-c?
No. Humanin and MOTS-c are both mitochondrial-derived peptides, but they are different peptides with different mechanisms and research focuses.
Is Humanin the same as Elamipretide?
No. Humanin is a mitochondrial-derived peptide encoded by mitochondrial DNA. Elamipretide is a mitochondria-targeted cardiolipin-binding peptide approved as Forzinity for a specific Barth syndrome indication.
Does Humanin help Alzheimer's disease?
Humanin has preclinical neuroprotective evidence related to Alzheimer's disease models, but it is not an FDA-approved Alzheimer's treatment and human clinical benefit is not established.
Does Humanin improve insulin sensitivity?
Preclinical research suggests Humanin may influence insulin sensitivity and metabolic regulation, but it is not an FDA-approved diabetes or insulin-resistance treatment.
Is Humanin an anti-aging peptide?
Humanin is studied in aging biology, but strong human evidence does not establish it as an anti-aging or longevity therapy.
Is Humanin safe?
Humanin does not have enough human safety data to call it safe for consumer use. Online Humanin products also create identity, purity, sterility, concentration, absorption, and contamination risks.
Is Humanin banned in sports?
No official WADA source was found here specifically naming Humanin as prohibited. Athletes should verify current status with WADA, USADA, or Global DRO before use.
Sources
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]WADA: Prohibited List
Anti Doping
- [17]USADA: WADA Prohibited List Guidance
Anti Doping
Last updated May 9, 2026